Identification of claudin-3 as an entry factor for rat hepacivirus
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2508736122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Tomohisa Tanaka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi 409-3898, Japan. Hauptthemen laut MEDLINE: Hepacivirus, Virus Internalization, Claudin-3. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS), MEXT | Japan Science and Technology Agency (JST).
Abstract (Originalsprache)
Approximately 58 million people worldwide are believed to be infected with hepatitis C virus (HCV), a major causative agent of chronic liver diseases. Hepacivirus ratti strain rn-1, which was discovered from Rattus norvegicus (Norway rat) and designated Norway rat hepacivirus 1 (NRHV1), shares similar properties with HCV in terms of genetic homology, target cell tropism, pathogenicity, and the immune response. In vivo infection systems for NRHV1 will help overcome the challenges in HCV research for vaccine development. However, the virological characteristics of NRHV1, such as the mechanisms of cell entry, remain largely unexplored, in part owing to a paucity of cell culture systems for NRHV1. Here, we identified the host factors that facilitate NRHV1 entry by profiling the gene expression of two cell lines with different susceptibilities to NRHV1 infection. NRHV1 employs rodent orthologues of HCV entry factors, including scavenger receptor class BI, CD81, and occludin, and utilizes claudin-3 (CLDN3) but not claudin-1. The expression of rat and mouse, but not human, CLDN3 facilitates the entry of NRHV1 into murine cell lines that are nonsusceptible to NRHV1 infection. The host-specific cell entry of CLDN3 is determined by two amino acid residues, Ile 44 and Trp 46 , in extracellular loop 1. These findings suggest that CLDN3 serves as an entry factor for rat hepacivirus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi 409-3898, Japan.
- Division of Hepatitis Virology, Institute for Genetic Medicine, Hokkaido University, Hokkaido 060-0815, Japan.
- Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
- Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
- Center for Life Science Research, University of Yamanashi, Yamanashi 409-3898, Japan.
ORCID-Profile: Tomohisa Tanaka, Yoshiharu Matsuura, Kohji Moriishi
Förderung
- Japan Agency for Medical Research and Development (AMED)
- MEXT | Japan Society for the Promotion of Science (JSPS)
- MEXT | Japan Science and Technology Agency (JST)
- Takeda Science Foundation (TSF)
- Yakult Honsha (Yakult)
Zitieren
APA
Tanaka, T., Akaike, Y., Kasai, H., Yamashita, A., Matsuura, Y., & Moriishi, K. (2025). Identification of claudin-3 as an entry factor for rat hepacivirus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2508736122
Vancouver
Tanaka T, Akaike Y, Kasai H, Yamashita A, Matsuura Y, Moriishi K. Identification of claudin-3 as an entry factor for rat hepacivirus. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2508736122
BibTeX
@article{Tanaka2025,
author = {Tanaka, Tomohisa and Akaike, Yasunori and Kasai, Hirotake and Yamashita, Atsuya and Matsuura, Yoshiharu and Moriishi, Kohji},
title = {Identification of claudin-3 as an entry factor for rat hepacivirus},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2508736122}
}
EUVIMED